pd-l1 expression in nsclc
Published 5 years ago • 290 plays • Length 3:50Download video MP4
Download video MP3
Similar videos
-
1:53
dr. garassino discusses pros with durvalumab by pd-l1 expression in stage iii nsclc
-
1:12
dr. villaruz discusses pd-l1 expression in lung cancer
-
1:42
dr. desai on immunotherapy in patients with nsclc and low pd-l1 expression
-
1:10
dr. gubens on prevalence of egfr/alk/ros1 and pd-l1 expression in nsclc
-
3:22
the significance of pd-l1 expression in nsclc
-
1:21
poet: the predictive and prognostic value of pd-l1 expression in nsclc
-
1:20
how does pd-l1 impact treatment options for lung cancer?
-
30:02
pd-l1 expression in early nsclc: interpreting the data so far | heather wakelee & nasser altorki
-
5:44
reliability of pd-l1 testing in nsclc
-
5:26
cemiplimab efficacy by pd-l1 expression in the empower-lung 1 trial of nsclc
-
5:47
pd-l1 testing in metastatic nsclc
-
6:03
pd-l1 expression in metastatic urothelial cancer
-
7:55
pd-l1 expression in bladder cancer
-
7:09
pd-l1 testing in squamous nsclc
-
2:03
dr. natale on the utility of pd-l1 and tmb in lung cancer
-
3:37
problems with pd-l1 expression testing in patients with nsclc
-
8:03
driver mutations trump pd-l1 expression in lung adenocarcinoma
-
6:53
upfront pd-l1 blockade in newly diagnosed nsclc
-
1:50
pd-l1 agents in the treatment of nsclc